Analysis of linear accelerator-based fractionated stereotactic radiotherapy in brain metastases: efficacy, safety, and dose tolerances.

Front Oncol · 2024 · PMC11647529 · PMID 39687885

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

nearly significantP = 0.054so close (0.05 < p ≤ 0.1)

Stratified analysis highlighted nearly significant OS improvements with high-dose FSRT and targeted therapy ( P = 0.054), while concurrent therapy markedly enhanced iPFS ( P = 0.027).

also in 3,349 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.